Capricor

Question mark made of numbers
Biotech

FDA adcomm shoots down Capricor's Duchenne cell therapy

The panel voted nine to three against deramiocel, capping off an advisory committee marked by statistical confusion.
Darren Incorvaia Jul 29, 2026 6:06pm
dynamic arrows moving up

Capricor sets up 2nd DMD approval attempt with ph. 3 win

Dec 3, 2025 11:11am
Doctor working on iPad with hospital setting in background

Capricor finds efficacy in older Duchenne patients in phase 2

Sep 24, 2021 7:00am
DNA

Capricor yo-yos as J&J dumps stem cell partnership

Jul 7, 2017 9:58am